These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

353 related items for PubMed ID: 10066093

  • 1. Urokinase induces receptor mediated brain tumor cell migration and invasion.
    MacDonald TJ, DeClerck YA, Laug WE.
    J Neurooncol; 1998 Dec; 40(3):215-26. PubMed ID: 10066093
    [Abstract] [Full Text] [Related]

  • 2. Modulation of invasive properties of human glioblastoma cells stably expressing amino-terminal fragment of urokinase-type plasminogen activator.
    Mohanam S, Chandrasekar N, Yanamandra N, Khawar S, Mirza F, Dinh DH, Olivero WC, Rao JS.
    Oncogene; 2002 Nov 07; 21(51):7824-30. PubMed ID: 12420219
    [Abstract] [Full Text] [Related]

  • 3. [Mechanism of tumor cell-induced extracellular matrix degradation--inhibition of cell-surface proteolytic activity might have a therapeutic effect on tumor cell invasion and metastasis].
    Kobayashi H.
    Nihon Sanka Fujinka Gakkai Zasshi; 1996 Aug 07; 48(8):623-32. PubMed ID: 8808830
    [Abstract] [Full Text] [Related]

  • 4. Insulinlike growth factor-I-mediated migration and invasion of human colon carcinoma cells requires activation of c-Met and urokinase plasminogen activator receptor.
    Bauer TW, Fan F, Liu W, Johnson M, Parikh NU, Parry GC, Callahan J, Mazar AP, Gallick GE, Ellis LM.
    Ann Surg; 2005 May 07; 241(5):748-56; discussion 756-8. PubMed ID: 15849510
    [Abstract] [Full Text] [Related]

  • 5. Melanoma cell migration on vitronectin: regulation by components of the plasminogen activation system.
    Stahl A, Mueller BM.
    Int J Cancer; 1997 Mar 28; 71(1):116-22. PubMed ID: 9096674
    [Abstract] [Full Text] [Related]

  • 6. TGF-β2 promotes RPE cell invasion into a collagen gel by mediating urokinase-type plasminogen activator (uPA) expression.
    Sugioka K, Kodama A, Okada K, Iwata M, Yoshida K, Kusaka S, Matsumoto C, Kaji H, Shimomura Y.
    Exp Eye Res; 2013 Oct 28; 115():13-21. PubMed ID: 23810810
    [Abstract] [Full Text] [Related]

  • 7. Epidermal growth factor modulates prostate cancer cell invasiveness regulating urokinase-type plasminogen activator activity. EGF-receptor inhibition may prevent tumor cell dissemination.
    Festuccia C, Angelucci A, Gravina GL, Biordi L, Millimaggi D, Muzi P, Vicentini C, Bologna M.
    Thromb Haemost; 2005 May 28; 93(5):964-75. PubMed ID: 15886816
    [Abstract] [Full Text] [Related]

  • 8. uPA and uPAR contribute to NK cell invasion through the extracellular matrix.
    Al-Atrash G, Kitson RP, Xue Y, Mazar AP, Kim MH, Goldfarb RH.
    Anticancer Res; 2001 May 28; 21(3B):1697-704. PubMed ID: 11497249
    [Abstract] [Full Text] [Related]

  • 9. Targeting of urokinase plasminogen activator receptor in human pancreatic carcinoma cells inhibits c-Met- and insulin-like growth factor-I receptor-mediated migration and invasion and orthotopic tumor growth in mice.
    Bauer TW, Liu W, Fan F, Camp ER, Yang A, Somcio RJ, Bucana CD, Callahan J, Parry GC, Evans DB, Boyd DD, Mazar AP, Ellis LM.
    Cancer Res; 2005 Sep 01; 65(17):7775-81. PubMed ID: 16140945
    [Abstract] [Full Text] [Related]

  • 10. RNA interference-directed knockdown of urokinase plasminogen activator and urokinase plasminogen activator receptor inhibits prostate cancer cell invasion, survival, and tumorigenicity in vivo.
    Pulukuri SM, Gondi CS, Lakka SS, Jutla A, Estes N, Gujrati M, Rao JS.
    J Biol Chem; 2005 Oct 28; 280(43):36529-40. PubMed ID: 16127174
    [Abstract] [Full Text] [Related]

  • 11. Urokinase-type plasminogen activation in three human breast cancer cell lines correlates with their in vitro invasiveness.
    Holst-Hansen C, Johannessen B, Høyer-Hansen G, Rømer J, Ellis V, Brünner N.
    Clin Exp Metastasis; 1996 May 28; 14(3):297-307. PubMed ID: 8674284
    [Abstract] [Full Text] [Related]

  • 12. Contrasting effects of plasminogen activators, urokinase receptor, and LDL receptor-related protein on smooth muscle cell migration and invasion.
    Okada SS, Grobmyer SR, Barnathan ES.
    Arterioscler Thromb Vasc Biol; 1996 Oct 28; 16(10):1269-76. PubMed ID: 8857924
    [Abstract] [Full Text] [Related]

  • 13. Urokinase receptor-dependent upregulation of smooth muscle cell adhesion to vitronectin by urokinase.
    Chang AW, Kuo A, Barnathan ES, Okada SS.
    Arterioscler Thromb Vasc Biol; 1998 Dec 28; 18(12):1855-60. PubMed ID: 9848876
    [Abstract] [Full Text] [Related]

  • 14. Interleukin-1alpha enhances the aggressive behavior of pancreatic cancer cells by regulating the alpha6beta1-integrin and urokinase plasminogen activator receptor expression.
    Sawai H, Okada Y, Funahashi H, Matsuo Y, Takahashi H, Takeyama H, Manabe T.
    BMC Cell Biol; 2006 Feb 20; 7():8. PubMed ID: 16504015
    [Abstract] [Full Text] [Related]

  • 15. Plasminogen activator system modulates invasive capacity and proliferation in prostatic tumor cells.
    Festuccia C, Dolo V, Guerra F, Violini S, Muzi P, Pavan A, Bologna M.
    Clin Exp Metastasis; 1998 Aug 20; 16(6):513-28. PubMed ID: 9872599
    [Abstract] [Full Text] [Related]

  • 16. Overexpression of urokinase receptor increases matrix invasion without altering cell migration in a human osteosarcoma cell line.
    Karikó K, Kuo A, Boyd D, Okada SS, Cines DB, Barnathan ES.
    Cancer Res; 1993 Jul 01; 53(13):3109-17. PubMed ID: 8391387
    [Abstract] [Full Text] [Related]

  • 17. Amino-terminal fragment of urokinase inhibits tumor cell invasion in vitro and in vivo: respective contribution of the urokinase plasminogen activator receptor-dependent or -independent pathway.
    Li H, Soria C, Griscelli F, Opolon P, Soria J, Yeh P, Legrand C, Vannier JP, Belin D, Perricaudet M, Lu H.
    Hum Gene Ther; 2005 Oct 01; 16(10):1157-67. PubMed ID: 16218777
    [Abstract] [Full Text] [Related]

  • 18. Role of urokinase plasminogen activator receptor in thrombospondin 1-mediated tumor cell invasion.
    Albo D, Berger DH, Rothman VL, Tuszynski GP.
    J Surg Res; 1999 Apr 01; 82(2):331-8. PubMed ID: 10090848
    [Abstract] [Full Text] [Related]

  • 19. Urokinase plasminogen activator/urokinase-specific surface receptor expression and matrix invasion by breast cancer cells requires constitutive p38alpha mitogen-activated protein kinase activity.
    Huang S, New L, Pan Z, Han J, Nemerow GR.
    J Biol Chem; 2000 Apr 21; 275(16):12266-72. PubMed ID: 10766865
    [Abstract] [Full Text] [Related]

  • 20. Osteopontin(OPN)-induced increase in human mammary epithelial cell invasiveness is urokinase (uPA)-dependent.
    Tuck AB, Hota C, Chambers AF.
    Breast Cancer Res Treat; 2001 Dec 21; 70(3):197-204. PubMed ID: 11804183
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.